Benzinga | Aug 9, 2021 04:11PM EDT

Aziyo Biologics Q2 EPS $(0.23) Beats $(0.53) Estimate, Sales $12.20M Beat $12.04M Estimate

Aziyo Biologics (NASDAQ:AZYO) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.53) by 56.6 percent. The company reported quarterly sales of $12.20 million which beat the analyst consensus estimate of $12.04 million by 1.33 percent.